Mikihiro Yunoki
9PUBLICATIONS
1CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|May 13, 2024
Anti-monkeypox virus-neutralizing activities of human immunoglobulin manufactured between 1999 and 2021 and derived from donors in the United States and Japan.Mikihiro Yunoki, Ritsuko Kubota-Koketsu, Tatsuo Shioda
|May 24, 2023
Changes in Anti-SARS-CoV-2 Antibody Titers of Pooled Plasma Derived From Donors in Japan: A Potential Tool for Mass-Immunity Evaluation.Mikihiro Yunoki, Ritsuko Kubota-Koketsu, Teruaki Imada
|Mar 20, 2023
Decline in intravenous immunoglobulin titer against influenza virus A/H2N2 derived from donors in Japan.Mikihiro Yunoki, Ritsuko Kubota-Koketsu, Tatsuo Shioda
|Jun 06, 2022
Long-term monitoring of antibody titers against microorganisms in human intravenous immunoglobulin lots derived from healthy donors in Japan manufactured during 1998-2018.Mikihiro Yunoki, Risa Nakagawa, Hiroyuki Onodera
|Aug 08, 2021
Assessment of the potentially decreased neutralizing activities of intravenous immunoglobulin against future coronavirus variants.Takamasa Inoue, Mikihiro Yunoki, Ritsuko Kubota-Koketsu
|May 31, 2021
Screening for parvovirus B19 antigen through chemiluminescent enzyme immunoassay is equivalent to B19 nucleic acid amplification test-based screening of pooled plasma.Motonori Ikegawa, Shinichi Ohashi, Takao Minagi
Pageof 2
